Ligand validation:6GM9

GLC: alpha-D-glucopyranose

GLC is a Ligand Of Interest in 6GM9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6GM9_GLC_A_308	66%	89%	0.131	0.936	0.17	0.45	-	-	0	0	100%	0.59
6RQI_GLC_A_306	96%	94%	0.066	0.977	0.12	0.31	-	-	0	0	100%	0.71
6RKN_GLC_A_308	93%	91%	0.073	0.968	0.16	0.4	-	-	0	0	100%	0.69
6RIG_GLC_A_305	91%	87%	0.081	0.966	0.23	0.47	-	-	0	0	100%	0.78
6SEY_GLC_A_306	90%	95%	0.074	0.958	0.14	0.26	-	-	0	0	100%	0.72
6RH4_GLC_A_306	89%	92%	0.085	0.965	0.11	0.41	-	-	0	0	100%	0.67
5O59_GLC_A_608	100%	61%	0.025	0.992	0.81	0.69	-	-	0	0	92%	0.9167
8R4G_GLC_C_1001	100%	39%	0.042	0.991	0.8	1.57	1	3	1	0	100%	1
3W7S_GLC_A_1002	99%	64%	0.046	0.974	0.56	0.83	-	-	0	0	100%	1
5MTT_GLC_A_407	98%	66%	0.053	0.993	0.38	0.92	-	-	0	0	92%	0.5867
8R53_GLC_A_901	98%	61%	0.047	0.969	0.78	0.72	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.